株式会社ゲノムクリニック

Genome Clinic researches and develops technologies that contribute to people's health, aiming for medical implementation.

Based based in Tokyo, Japan, 株式会社ゲノムクリニック works in medtech.

Profile

"Genome Clinic is a pioneering medtech company dedicated to researching and developing technologies that enhance people's health, with a focus on medical implementation. Utilizing genome and DNA analysis as its core technology, Genome Clinic aims to contribute to the well-being of individuals by developing innovative health-related technologies. One of their key services includes assessing environmental risks related to the novel coronavirus by combining environmental and individual evaluations to provide tailored recommendations for appropriate actions. Additionally, Genome Clinic offers on-site services for evaluating surfaces and air for the presence of the novel coronavirus, conducted by specialized staff using dedicated equipment. Their efforts also extend to genetic risk assessment for breast and ovarian cancer through the analysis of BRCA1 and BRCA2 genes, enabling individuals to proactively assess their risk of developing these cancers and seek timely treatment through appropriate screenings. Furthermore, Genome Clinic is actively involved in developing new genome analysis methods to expand their impact on public health. This includes research on polygenic risk scores (PRS)

As a business in medtech, 株式会社ゲノムクリニック is listed here with the public details available about it.

The business is associated with Tokyo, Japan.

The company is listed at the Plug and Play portfolio startup stage of development.

Website: genome-clinic.co.jp